Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Momordica foetida
African cucurbit used in traditional medicine for malaria, diabetes, and skin conditions.
Momordica foetida, a cucurbit used in East African traditional medicine, demonstrates antimalarial, antidiabetic, and anti-inflammatory properties attributed to cucurbitacins, charantin, and flavonoids. Despite limited clinical evidence (Level C), its traditional use for malaria, diabetes, and skin conditions is supported by preliminary pharmacological studies. The herb poses significant risks during pregnancy and may interact with hypoglycemic agents.
Cucurbitacins inhibit STAT3 and JAK/STAT signaling pathways, reducing inflammation and inducing apoptosis in cancer cells. Charantin and related compounds enhance glucose uptake via AMPK activation and GLUT4 translocation, mimicking insulin-like effects. Flavonoids contribute antioxidant and anti-inflammatory actions through NF-κB inhibition. Antimalarial activity may involve disruption of Plasmodium membrane integrity and inhibition of heme polymerization.
African cucurbit used in traditional medicine for malaria, diabetes, and skin conditions.
Momordica foetida, a cucurbit used in East African traditional medicine, demonstrates antimalarial, antidiabetic, and anti-inflammatory properties attributed to cucurbitacins, charantin, and flavonoids. Despite limited clinical evidence (Level C), its traditional use for malaria, diabetes, and skin conditions is supported by preliminary pharmacological studies. The herb poses significant risks during pregnancy and may interact with hypoglycemic agents.
Cucurbitacins inhibit STAT3 and JAK/STAT signaling pathways, reducing inflammation and inducing apoptosis in cancer cells. Charantin and related compounds enhance glucose uptake via AMPK activation and GLUT4 translocation, mimicking insulin-like effects. Flavonoids contribute antioxidant and anti-inflammatory actions through NF-κB inhibition. Antimalarial activity may involve disruption of Plasmodium membrane integrity and inhibition of heme polymerization.